Inhibikase Therapeutics (IKT) Net Income (2020 - 2026)
Inhibikase Therapeutics' Net Income came in at -$21.05 million for Q2 2026, compared with -$10.83 million a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Net Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inhibikase Therapeutics reported Net Income of -$65.44 million; for FY2025, it came in at -$51.97 million.
- Going back by year, Net Income was -$28.59 million in FY2024, -$20.09 million in FY2023, -$18.13 million in FY2022 and -$14.79 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Net Income in data going back to Q1 2020.
- Business Quant data shows IKT's Net Income at -$17.84 million (Q1 2026), -$13.78 million (Q4 2025) and -$12.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -20.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -20.47 Mn |
| Jun 30, 2026 | -19.59 Mn |
| Mar 31, 2026 | -16.38 Mn |
| Dec 31, 2025 | -12.73 Mn |
| Sep 30, 2025 | -11.93 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -13.68 Mn |
| Dec 31, 2024 | -12.13 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Jun 30, 2024 | -4.96 Mn |
| Mar 31, 2024 | -4.65 Mn |
| Dec 31, 2023 | -4.18 Mn |
| Sep 30, 2023 | -4.60 Mn |
| Jun 30, 2023 | -5.78 Mn |
| Mar 31, 2023 | -4.48 Mn |
| Dec 31, 2022 | -4.28 Mn |
| Sep 30, 2022 | -4.49 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.64 Mn |
| Dec 31, 2021 | -5.04 Mn |
API Access
Inhibikase Therapeutics Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();